FENNEC PHARMACEUTICALS INC. Quarterly Operating Margin in % from Q4 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Fennec Pharmaceuticals Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q3 2024.
  • Fennec Pharmaceuticals Inc. Operating Margin for the quarter ending September 30, 2024 was 3.41 %.
  • Fennec Pharmaceuticals Inc. annual Operating Margin for 2023 was -60.1 %, a 95.9% increase from 2022.
  • Fennec Pharmaceuticals Inc. annual Operating Margin for 2022 was -1.47K %.
Operating Margin, Quarterly (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 3.41 Jul 1, 2024 Sep 30, 2024
Q2 2024 12 Apr 1, 2024 Jun 30, 2024
Q1 2024 13.9 Jan 1, 2024 Mar 31, 2024
Q4 2023 -60.1 Oct 1, 2023 Dec 31, 2023
Q1 2021 -9.49K Jan 1, 2021 Mar 31, 2021
Q4 2020 -8.94K Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.